Regeneron Pharmaceuticals Inc. buy Kilianhammernick
Start price
13.10.21
/
50%
€470.00
Target price
13.10.22
-
Performance (%)
24.89%
End price
13.03.22
€587.00
Summary
This prediction ended on 13.03.22 with a price of €587.00. The prediction had a final performance of 24.89%. Kilianhammernick has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -0.125% | -0.125% | 28.843% | -13.388% |
| iShares Core DAX® | 3,59 % | 6,43 % | 15,38 % | 52,31 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % | 41,46 % | 91,77 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % | 48,95 % | 65,86 % |
| iShares S&P 500 | 4,14 % | 4,94 % | 31,59 % | 65,33 % |
Comments by Kilianhammernick for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Kilianhammernick hat das Wertpapier Regeneron Pharmaceuticals Inc. in seinem Wikifolio Alternative Invest gekauft.